Gene Transfer of CGMP-dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes
Overview
Authors
Affiliations
NO acting through soluble guanylyl cyclase and cGMP formation is a negative regulator of cardiomyocyte hypertrophy. Downstream targets mediating the inhibitory effects of NO/cGMP on cardiomyocyte hypertrophy have not been elucidated. In addition to its antihypertrophic effects, NO promotes apoptosis in cardiomyocytes, presumably through cGMP-independent pathways. We investigated the role of cGMP-dependent protein kinase (PKG) in the antihypertrophic and proapoptotic effects of NO. Incubation of neonatal rat cardiomyocytes with the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) (250 micromol/L) or the PKG-selective cGMP analog 8-pCPT-cGMP (500 micromol/L) activated endogenous PKG type I, as shown by the site-specific phosphorylation of vasodilator-stimulated phosphoprotein, a well-characterized PKG substrate. SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) modestly attenuated the hypertrophic response to alpha(1)-adrenergic stimulation with phenylephrine. Although a high concentration of SNAP (1000 micromol/L) promoted apoptosis in cardiomyocytes, as evidenced by the formation of histone-associated DNA fragments, antihypertrophic concentrations of SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) did not promote cell death. Because chronic activation downregulated endogenous PKG I, we explored whether gene transfer of PKG I would enhance the sensitivity of cardiomyocytes to the antihypertrophic effects of NO/cGMP. Indeed, after adenoviral overexpression of PKG Ibeta, SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) completely suppressed the hypertrophic response to alpha(1)-adrenergic stimulation. As observed in noninfected cells, SNAP (250 micromol/L) and 8-pCPT-cGMP (500 micromol/L) did not promote apoptosis in cardiomyocytes overexpressing PKG Ibeta. Moreover, overexpression of PKG Ibeta did not enhance the proapoptotic effects of 1000 micromol/L SNAP, implying PKG-independent effects of NO on apoptosis. Endogenous PKG I mediates antihypertrophic but not proapoptotic effects of NO in a cell culture model of cardiomyocyte hypertrophy. Adenoviral gene transfer of PKG I selectively enhances the antihypertrophic effects of NO without increasing the susceptibility to apoptosis.
The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies.
Cai Z, Wu C, Xu Y, Cai J, Zhao M, Zu L Aging Dis. 2023; 14(1):46-62.
PMID: 36818566 PMC: 9937694. DOI: 10.14336/AD.2022.0523.
Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M, Li Y, Li S, Lv J Front Endocrinol (Lausanne). 2022; 13:851941.
PMID: 35464057 PMC: 9021409. DOI: 10.3389/fendo.2022.851941.
Pradeep R, Akram A, Proute M, Kothur N, Georgiou P, Serhiyenia T Cureus. 2021; 13(8):e17548.
PMID: 34646605 PMC: 8481153. DOI: 10.7759/cureus.17548.
Gamrat A, Surdacki M, Chyrchel B, Surdacki A J Clin Med. 2020; 9(7).
PMID: 32635218 PMC: 7408687. DOI: 10.3390/jcm9072090.
Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.
Preedy M Cardiovasc Drugs Ther. 2020; 34(3):401-417.
PMID: 32172427 PMC: 7242274. DOI: 10.1007/s10557-020-06959-1.